Baseimmune
Baseimmune is a biotech startup founded to create the next generation of vaccines.
Baseimmune has raised €4.9M across 2 funding rounds from 6 investors, most recently a round in Nov 2021. Based in London, UK; founded 2019; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€4.9M
€4,949,700
Funding rounds
2
Investors
6
distinct backers
Active since
2021-04
latest 2021-11
Funding by year
EUR raised per yearBaseimmune — funding by year — interactive chart.
Data table
| Baseimmune — funding by year | |
|---|---|
| 2021 | €4.9M |
Signals
High confidenceRaise-next likelihood6
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood8
base rate 11% (2+ rounds)
- ▲ 7y since founding (typical exit age)
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-11-03 | Other | €4.1M | Beast Ventures,Cherry Ventures,Creator Fund,Hoxton Ventures,Maki.vc,Rockmount | View deal → |
| 2021-04-01 | Seed | €804k | Creator Fund | View deal → |